Eton Pharmaceuticals Aktie
WKN DE: A2N38G / ISIN: US29772L1089
|
16.04.2026 14:02:40
|
Eton Pharmaceuticals Names Judith Matthews CFO, Effective June 1
(RTTNews) - Eton Pharmaceuticals Inc. (ETON) on Thursday said it has appointed Judith M. Matthews as Executive Vice President, Accounting and Finance, effective immediately.
Matthews will assume the role of Chief Financial Officer on June 1, 2026, succeeding James Gruber, who will step down as part of a planned succession.
Matthews brings more than 25 years of finance leadership experience and previously served as Chief Financial Officer at Iterum Therapeutics plc from 2015 to 2026.
On Wednesday, Eton shares closed at $26.97, down 0.55%.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eton Pharmaceuticals Inc Registered Shs
|
18.03.26 |
Ausblick: Eton Pharmaceuticals vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
|
05.03.26 |
Erste Schätzungen: Eton Pharmaceuticals legt Quartalsergebnis vor (finanzen.net) | |
|
05.11.25 |
Ausblick: Eton Pharmaceuticals zieht Bilanz zum abgelaufenen Quartal (finanzen.net) |
Analysen zu Eton Pharmaceuticals Inc Registered Shs
Aktien in diesem Artikel
| Eton Pharmaceuticals Inc Registered Shs | 25,28 | 0,96% |
|